In 2017, extensive research into multiple sclerosis (MS) resulted in improved diagnostic criteria, development of biomarkers that enable monitoring of disease evolution and treatment response over time, and identification of novel genetic markers of disease susceptibility. In addition, 2017 saw the first successful clinical trials of remyelination strategies and treatments for progressive MS.
Multiple sclerosis in 2017: Progress in multiple sclerosis - from diagnosis to therapy / Trojano, Maria; Amato, Maria Pia. - In: NATURE REVIEWS. NEUROLOGY. - ISSN 1759-4766. - STAMPA. - 14:(2018), pp. 72-74. [10.1038/nrneurol.2018.3]
Multiple sclerosis in 2017: Progress in multiple sclerosis - from diagnosis to therapy
Amato, Maria Pia
2018
Abstract
In 2017, extensive research into multiple sclerosis (MS) resulted in improved diagnostic criteria, development of biomarkers that enable monitoring of disease evolution and treatment response over time, and identification of novel genetic markers of disease susceptibility. In addition, 2017 saw the first successful clinical trials of remyelination strategies and treatments for progressive MS.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
